Public company info
Input the stock code or the company name     Search  
 


 Stock code   01541 
 Company name  ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
 Region  Hong Kong
 Type  MB
 Website  
 Quote  0.0 

Company profile  |  Business review  |  Prospect  |  Latest results  |  Financial ratios
Income statement  |  Cash flow statement  |  Balance sheet  |  Entitlement
Disclosure of interest  |  Quote

 Related stock news
  宜明昂科附屬引入三名外部投資者 增資...  2026-08-07T  
  宜明昂科IMM0306治療IgG4相...  2026-07-10T  
  宜明昂科IMM0306 III期臨床...  2026-03-31T  
  《業績》宜明昂科全年虧損收窄至2.1...  2026-03-26T  
  宜明昂科完成招募IMM01臨床試驗患...  2026-03-23T  
  宜明昂科IMM0306S新藥臨床試驗...  2026-03-08T  
  宜明昂科核心產品IMM01完成III...  2026-01-21T  
  宜明昂科IMM01用於治療動脈粥樣硬...  2026-01-12T  
  宜明昂科終止授權協議 重獲IMM25...  2026-01-06T  
  宜明昂科董事長增持5萬股 均價6.6...  2025-12-03T  
  Search   More 
 Latest News
  南向資金今日淨賣出超106億 港元 ...  2026-08-19T17:  
  ...瑞銀:黃金中期漲勢未完 預計明...  2026-08-19T17:  
  恆安料全年紙品業務持平或略低 第三季...  2026-08-19T  
  《藍籌》快手次季經調整利潤按年跌30...  2026-08-19T  
  紐約匯市: 美元 隨油價上漲 日元 ...  2026-08-19T05:  
  A50 增強 ETF 富國(5632...  2026-08-19T03:  
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.